(Q45038781)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Aparajita Dey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Roger S Williams

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

David M Pollock

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

David W Stepp

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Bruce D Hammock

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

John D Imig

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

1 reference

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1278-1289

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15340111%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of obesity-associated cardiovascular and renal disease

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Treatment of obesity hypertension and diabetes syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Hyperphagia as a mediator of renal disease initiation in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

The Zucker fatty rat as a genetic model of obesity and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Treatment of diabetic nephropathy in its early stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

P-450 metabolites of arachidonic acid in the control of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Isolation of preferentially expressed genes in the kidneys of hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Epoxygenase pathways of arachidonic acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Linoleic acid metabolites act to increase contractility in isolated rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Tissue phospholipid fatty acid composition in genetically lean (Fa/-) or obese (fa/fa) Zucker female rats on the same diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Cyclooxygenase-2 inhibition and renal physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Effects of indomethacin on glomerular hemodynamics in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Altered pressure-natriuresis in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-beta bioactivity in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Inhibition of COX-2 counteracts the effects of diuretics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Eicosanoid regulation of the renal vasculature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Expression of a male-specific cytochrome P450 isozyme (CYP2C11) in fa/fa Zucker rats: effect of phenobarbital treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Cyclooxygenase-2 inhibitors: will they help us prevent diabetic nephropathy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Evidence for endothelin involvement in the response to high salt

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Prostaglandin synthesis and membrane fatty acid composition in the heart of obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Reduction of urinary albumin excretion by thromboxane synthetase inhibitor, OKY-046, through modulating renal prostaglandins in patients with diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Effects of thromboxane synthetase inhibitor (OKY-046) on urinary prostaglandin excretion and renal function in streptozotocin-induced diabetic rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

A thromboxane A2 synthetase inhibitor retards hypertensive rat diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Prostaglandins and diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Increased renal TXA2 synthesis in diabetes mellitus: simultaneous determination of urinary TXB2 and 2,3-dinor-TXB2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162

inferred from DOI database lookup

7 January 2021

based on heuristic

Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.162